Merit Medical Systems Inc.

About Merit Medical Systems Inc.

Merit Medical Systems, Inc., founded in 1987, is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures. The company focuses on cardiology, radiology, oncology, critical care, and endoscopy, serving client hospitals and physicians worldwide with approximately 7,000 employees.

Products & Services

Prelude Wave™ Hydrophilic Sheath Introducer with SnapFix™ Technology:A device designed to advance radial access and overcome sheath securement challenges with a thin-wall design and unique retention features.

StatSeal & WoundSeal:Hemostasis products added to Merit's portfolio to standardize, simplify, and minimize post-procedure care across various procedures.

Embosphere Microspheres:Achieved CE Mark for Genicular Artery Embolisation to treat knee osteoarthritis.

SCOUT:Wire-free technology used to treat 750,000 patients.

WRAPSODY:Part of a North America Registry with the first patient enrolled.

Product Categories:Includes Access, Accessories, Balloons, Biopsy, Cardiac Rhythm Management, Catheters, Compression, Critical Care, Dialysis Access, Drainage, Electrophysiology, Embolics & Delivery Systems, GERD Treatment, Guide Wires, Inflation Devices, Interventional Spine, Kits and Packs, Monitoring Devices, Needles, Oncology, Safety, Snares, Stents, and Syringes.

Procedural Solutions:Covers Biopsy Solutions, Cardiac Catheterization, Critical Care Solutions, Dialysis Access, Distal Radial Access, Drainage Solutions, Embolotherapy, EP & CRM, Gastroenterology Stricture Management, Inflation Devices, Kits and Packs, Peritoneal Dialysis Solutions, Prostatic Artery Embolization, Pulmonary Stricture Management, Radial Access, Spine, Uterine Fibroid Embolization, and Venous Solutions.

Specialties

Breast Surgery Critical Care Electrophysiology Gastroenterology Interventional Cardiology Interventional Radiology Nephrology Oncology Pulmonology Radiology Surgery Cardiology Diagnostic Procedures Therapeutic Procedures Endoscopy

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Convertible Senior Notes T: - FT: Convertible Senior Notes	A: 650000000 MR: - FA: $650.0 million FAN: 650000000	D: 2023-12-06 FD: 2023-12-06	-
2	RT: Convertible Senior Notes T: - FT: Convertible Senior Notes	A: 550000000 MR: - FA: $550 million FAN: 550000000	D: 2023-12-04 FD: 2023-12-04	-
3	RT: Debt T: - FT: Debt	A: 242000000 MR: - FA: $242 million FAN: 242000000	D: 2023-06-07 FD: 2023-06-07	1 investors

Convertible Senior Notes Latest

2023-12-06

$650.0M

Convertible Senior Notes 2023-12-04

$550.0M

Debt 2023-06-07

$242.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

F

Fred Lampropoulos

Founder, Chairman of the Board

F

F. Ann Millner

Lead Independent Director

LinkedIn (Pro only)

L

Lonny J. Carpenter

Director

S

Stephen C. Evans

Director

L

Lynne N. Ward

Chair of the Audit Committee

M

Michael McDonnell

Director

View 18 more team members with Pro

Unlock Full Team Directory

Recent News